What Is BPC-157?
BPC-157, also known as Body Protection Compound-157, is a pentadecapeptide (a 15-amino acid peptide sequence) first described in 1992. It is derived from a larger protein called BPC (Body Protection Compound) that naturally occurs in human gastric fluid, where it functions to maintain mucosal integrity and promote gastrointestinal homeostasis.
The synthetic version used in research and by the peptide community is a stable fragment of this naturally occurring compound. Unlike many peptides that degrade rapidly in the digestive system, BPC-157 demonstrates remarkable stability in gastric acid, which has contributed to interest in both injectable and oral administration routes.What distinguishes BPC-157 from other regenerative peptides is its broad spectrum of proposed effects. Preclinical research has demonstrated cytoprotective properties across multiple organ systems, including the gastrointestinal tract, liver, pancreas, heart, and nervous system. However, its primary appeal lies in musculoskeletal applications; specifically its potential to accelerate healing of tendons, ligaments, muscles, and bones. For a comparison with another leading recovery peptide, see our [BPC-157 vs TB-500 guide](/guides/bpc-157-vs-tb-500).
The primary human-use benefits proposed in preclinical (animal) studies include:
- Accelerated tendon and ligament repair
- Enhanced muscle healing following injury
- Reduced inflammation at injury sites
- Improved bone fracture healing
- Gastroprotective effects
- Potential neuroprotective properties
“What distinguishes BPC-157 from other regenerative peptides is its broad spectrum of proposed effects, cytoprotective properties across multiple organ systems, including the gastrointestinal tract, liver, pancreas, heart, and nervous system.”
How It Works
Angiogenesis and VEGF Upregulation
One of BPC-157's best-documented mechanisms involves stimulating angiogenesis and the formation of new blood vessels. Multiple preclinical studies have identified that BPC-157 increases vascular endothelial growth factor (VEGF) protein and gene expression, a critical pathway in tissue repair and regeneration. Enhanced blood vessel formation delivers more oxygen and nutrients to damaged tissues, accelerating the healing process.
Growth Factor and Cellular Proliferation Pathways
BPC-157 appears to upregulate several pro-survival and pro-proliferation pathways essential for tissue repair. Research has shown increased phosphorylation of extracellular signal-regulated kinases (ERK) 1 and 2, along with their downstream targets, including c-Fos, c-Jun, and Egr-1, which are molecules involved in cell growth, migration, and angiogenesis.
Additionally, BPC-157 has been associated with increased growth hormone receptor expression in tendon fibroblasts, suggesting it may enhance the body's responsiveness to growth hormone at the tissue level. The peptide also activates the FAK-paxillin pathway, important for cellular adhesion, migration, proliferation, and survival.
Anti-Inflammatory Effects
BPC-157 demonstrates significant anti-inflammatory properties through multiple mechanisms. Studies have observed decreased cyclooxygenase-2 (COX-2) gene expression, reduced myeloperoxidase activity, and lower levels of pro-inflammatory cytokines including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). In animal models of adjuvant-induced arthritis, BPC-157 reduced paw inflammation, nodule formation, and stiffness.
Nitric Oxide System Modulation
BPC-157 interacts significantly with the nitric oxide (NO) system, upregulating nitric oxide synthase (NOS) gene and protein expression while increasing nitric oxide production. This vasodilatory effect may contribute to improved blood flow to injured tissues and enhanced healing capacity.
“BPC-157 increases vascular endothelial growth factor (VEGF) expression, a critical pathway in tissue repair. Enhanced blood vessel formation delivers more oxygen and nutrients to damaged tissues, accelerating healing.”